Category: Uncategorized

ACS GREEN CHEMISTRY INSTITUTE Pharmaceutical Roundtable was created in 2005 with three pharma members that now numbers sixteen. The conversation finally began to adopt sustainable green manufacturing practices. " " http://pubs.acs.org/doi/pdf/10.1021/op400263a View in LinkedIn

GREEN SYNBIO POSTER CHILD. 1,3-propanediol green synthesis vs toxic chemical synthesis by " ""Conversion from corn syrup by a genetically modified strain of E. coli (DuPont Tate & Lyle BioProducts). An estimated 120,000 tons were produced in 2007. The Bio-PDO process uses 40% less energy than conventional processes, and reduces greenhouse gas emissions by 20%...the American Chemical Society awarded the Bio-PDO research teams the "2007 Heroes of Chemistry" award."" " http://lnkd.in/dRuC3hG View in LinkedIn

GREEN SYNTHETIC BIOLOGY. "Bioengineering is also seen as a promising technique for achieving green chemistry goals. A number of important process chemicals can be synthesized in engineered organisms, such as shikimate, a Tamiflu precursor which is fermented by Roche in bacteria."" " http://lnkd.in/dRuC3hG View in LinkedIn

GREEN CHEMISTRY is the transition from manufacturing using toxic chemicals petrochemicals to nontoxic chemicals that are cheaper, recyclable, and more sustainable. The majority of solvents used industrially are moderately to highly toxic. But building a library of candidate green solvents that have desirable industrial properties, as the Spanish company InKemia (an early innovator in Green Chemistry) has done, is more complex than building pharmaceutical libraries, and is orders of magnitude smaller. View in LinkedIn

GREEN CHEMISTRY "is the design of chemical products and processes that reduce or eliminate the use and generation of hazardous substances. Often referred to as a form of molecular- level pollution prevention, Green Chemistry relies on a set of 12 principles that can be used to design or re-design molecules, materials and chemical transformations to be safer for human health and the environment."" " http://greenchem.uoregon.edu/Pages/WhatIsGreenChemistry.php View in LinkedIn

MATERIALS GENOME INITIATIVE (2012): $100 M with "funding for the DOE, the DOF, the NSF, and the NIST. The initiative will support the development of computational tools, software, new methods for material characterization, and the development of open standards and databases that will make the process of discovery and development of advanced materials faster, less expensive, and more predictable." (Read the goals and funders carefully). " " http://materialsinnovation.tms.org/genome.aspx View in LinkedIn

HUMAN GENOME PROJECT did not anticipate either Big Data, nor Personalized Medicine driving a paradigm shift in medicine, nor epigenetics. In the moment, the excitement then was about the model of new genes leading to new disease tests which (proved to be correct). And that the discovery of a disease gene would lead to its associated protein -- and thus to a new drug target (this essentially proved to be wrong). Nor did it anticipate Bioinformatics. Nor the Synthetic Biology Revolution. And the story continues to unfold. Many unanticipated consequences. View in LinkedIn

BIG DATA IS BUILDING THE FUTURE OF EVERYTHING. "The Materials Genome Initiative has a database of millions of known and theoretical materials. The greater Materials Genome Initiative aims to reduce costs and time for material development."" " http://lnkd.in/dDjfXZh View in LinkedIn

NEW NIH BIG DATA CENTER OF EXCELLENCE known as Big Data to Knowledge (BD2K) to make quantum jump. "The goal of BD2K is to enhance the ability to analyze the ever-expanding amount of data of all types, enabling, by the end of this decade, a quantum leap in the ability of the biomedical research enterprise to maximize the value of the growing volume and complexity of biomedical data."" " http://lnkd.in/dMU5m2K View in LinkedIn

APP FOR PERSONALIZED MEDICINE. YarcData and Selventa developed a systems diagnostics tool (“SysDx”) which "harnesses a wide range of complex molecular biological information to deliver a level of personalized medicine that has been previously unavailable." "With 50 percent of drugs [being] ineffective or worse, there is an immediate opportunity to better match treatments to individuals based on their biomarker profiles."" " http://lnkd.in/dmaHBAr View in LinkedIn